Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Tapio Visakorpi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Physiology
Chemicals & Drugs
Anatomy
Phenomena
Living Beings
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
24
Isola, Jorma
24
Kallioniemi, Olli
23
Tammela, Teuvo
15
Saramäki, Outi
14
Nupponen, Nina
13
Porkka, Kati
13
Vessella, Robert
11
Koivisto, Pasi
10
Holli, Kaija
10
Linja, Marika
9
Hyytinen, Eija-Riitta
8
Waltering, Kati
8
Savinainen, Kimmo
6
Palmberg, C
6
Martikainen, Paula
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Tapio Visakorpi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Waltering Kati K; Helenius Merja A; Sahu Biswajyoti; Manni Visa; Linja Marika J; Jänne Olli A; Visakorpi Tapio
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Cancer research 2009;69(20):8141-9.
-
2009: Laurila Marita; Tammela Teuvo L J; Auvinen Anssi; Isola Jorma; Visakorpi Tapio; Luukkaala Tiina; Määttänen Liisa; Ruutu Mirja; Ala-Opas Martti; Mildh Markus; Martikainen Paula
Biological aggressiveness of prostate cancer in the Finnish screening trial.
International journal of cancer. Journal international du cancer 2009;124(3):547-52.
-
2009: Jalava Sanni E; Porkka Kati P; Rauhala Hanna E; Isotalo Jarkko; Tammela Teuvo L; Visakorpi Tapio
TCEB1 promotes invasion of prostate cancer cells.
International journal of cancer. Journal international du cancer 2009;124(1):95-102.
-
2009: Saramäki Outi R; Waltering Kati K; Visakorpi Tapio
Methods for identifying and studying genetic alterations in hormone-dependent cancers.
Methods in molecular biology (Clifton, N.J.) 2009;505():263-77.
-
2008: Ylösmäki Erkko; Hakkarainen Tanja; Hemminki Akseli; Visakorpi Tapio; Andino Raul; Saksela Kalle
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.
Journal of virology 2008;82(22):11009-15.
-
2008: Rauhala Hanna E; Porkka Kati P; Saramäki Outi R; Tammela Teuvo L J; Visakorpi Tapio
Clusterin is epigenetically regulated in prostate cancer.
International journal of cancer. Journal international du cancer 2008;123(7):1601-9.
-
2008: Murtola Teemu J; Visakorpi Tapio; Lahtela Jorma; Syvälä Heimo; Tammela Teuvo Lj
Statins and prostate cancer prevention: where we are now, and future directions.
Nature clinical practice. Urology 2008;5(7):376-87.
-
2008: Saramäki Outi R; Harjula Anna E; Martikainen Paula M; Vessella Robert L; Tammela Teuvo L J; Visakorpi Tapio
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3395-400.
-
2008: Abdulghani Junaid; Gu Lei; Dagvadorj Ayush; Lutz Jacqueline; Leiby Benjamin; Bonuccelli Gloria; Lisanti Michael P; Zellweger Tobias; Alanen Kalle; Mirtti Tuomas; Visakorpi Tapio; Bubendorf Lukas; Nevalainen Marja T
Stat3 promotes metastatic progression of prostate cancer.
The American journal of pathology 2008;172(6):1717-28.
-
2008: Laitinen Sari; Martikainen Paula M; Tolonen Teemu; Isola Jorma; Tammela Teuvo L J; Visakorpi Tapio
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
International journal of cancer. Journal international du cancer 2008;122(3):595-602.
-
2008: Tan Shyh-Han; Dagvadorj Ayush; Shen Feng; Gu Lei; Liao Zhiyong; Abdulghani Junaid; Zhang Ying; Gelmann Edward P; Zellweger Tobias; Culig Zoran; Visakorpi Tapio; Bubendorf Lukas; Kirken Robert A; Karras James; Nevalainen Marja T
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
Cancer research 2008;68(1):236-48.
-
2008: Alhopuro Pia; Karhu Auli; Winqvist Robert; Waltering Kati; Visakorpi Tapio; Aaltonen Lauri A
Somatic mutation analysis of MYH11 in breast and prostate cancer.
BMC cancer 2008;8():263.
-
2008: Urbanucci Alfonso; Waltering Kati K; Suikki Hanna E; Helenius Merja A; Visakorpi Tapio
Androgen regulation of the androgen receptor coregulators.
BMC cancer 2008;8():219.
-
2007: Laitinen Sari; Martikainen Paula M; Tammela Teuvo L J; Visakorpi Tapio
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
European urology 2007;52(3):725-32.
-
2007: Mäki H E; Saramäki O R; Shatkina L; Martikainen P M; Tammela T L J; van Weerden W M; Vessella R L; Cato A C B; Visakorpi T
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
The Journal of pathology 2007;212(4):395-401.
-
2007: Porkka Kati P; Pfeiffer Minja J; Waltering Kati K; Vessella Robert L; Tammela Teuvo L J; Visakorpi Tapio
MicroRNA expression profiling in prostate cancer.
Cancer research 2007;67(13):6130-5.
-
2007: Dagvadorj Ayush; Collins Sean; Jomain Jean-Baptiste; Abdulghani Junaid; Karras James; Zellweger Tobias; Li Hongzhen; Nurmi Martti; Alanen Kalle; Mirtti Tuomas; Visakorpi Tapio; Bubendorf Lukas; Goffin Vincent; Nevalainen Marja T
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Endocrinology 2007;148(7):3089-101.
-
2007: Scott Clare L; Gil Jésus; Hernando Eva; Teruya-Feldstein Julie; Narita Masako; Martínez Dolores; Visakorpi Tapio; Mu David; Cordon-Cardo Carlos; Peters Gordon; Beach David; Lowe Scott W
Role of the chromobox protein CBX7 in lymphomagenesis.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(13):5389-94.
-
2007: Georgitsi M; Karhu A; Winqvist R; Visakorpi T; Waltering K; Vahteristo P; Launonen V; Aaltonen L A
Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
British journal of cancer 2007;96(2):352-6.
-
2007: Visakorpi Tapio
[Not Available]
Duodecim; lääketieteellinen aikakauskirja 2007;123(11):1323-8.
-
2007: Saramaki Outi; Visakorpi Tapio
Chromosomal aberrations in prostate cancer.
Frontiers in bioscience : a journal and virtual library 2007;12():3287-301.
-
2006: Waltering Kati K; Wallén Mika J; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
The Prostate 2006;66(15):1585-91.
-
2006: Mäki Hanna E; Waltering Kati K; Wallén Mika J; Martikainen Paula M; Tammela Teuvo L J; van Weerden Wytske M; Vessella Robert L; Visakorpi Tapio
Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
The Prostate 2006;66(13):1391-8.
-
2006: Saramäki Outi R; Porkka Kati P; Vessella Robert L; Visakorpi Tapio
Genetic aberrations in prostate cancer by microarray analysis.
International journal of cancer. Journal international du cancer 2006;119(6):1322-9.
-
2006: Savinainen Kimmo J; Helenius Merja A; Lehtonen Heli J; Visakorpi Tapio
Overexpression of EIF3S3 promotes cancer cell growth.
The Prostate 2006;66(11):1144-50.
-
2006: Saramäki Outi R; Tammela Teuvo L J; Martikainen Paula M; Vessella Robert L; Visakorpi Tapio
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Genes, chromosomes & cancer 2006;45(7):639-45.
-
2006: Helenius Merja A; Savinainen Kimmo J; Bova G Steven; Visakorpi Tapio
Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
BJU international 2006;97(2):404-9.
-
2005: Sihto Harri; Puputti Marjut; Pulli Laura; Tynninen Olli; Koskinen Walter; Aaltonen Leena-Maija; Tanner Minna; Böhling Tom; Visakorpi Tapio; Bützow Ralf; Knuuttila Aija; Nupponen Nina N; Joensuu Heikki
Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.
Journal of molecular medicine (Berlin, Germany) 2005;83(12):976-83.
-
2005: Rauhala Hanna E; Porkka Kati P; Tolonen Teemu T; Martikainen Paula M; Tammela Teuvo L J; Visakorpi Tapio
Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
International journal of cancer. Journal international du cancer 2005;117(5):738-45.
-
2005: Marques Rute B; Erkens-Schulze Sigrun; de Ridder Corrina M; Hermans Karin G; Waltering Kati; Visakorpi Tapio; Trapman Jan; Romijn Johannes C; van Weerden Wytske M; Jenster Guido
Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
International journal of cancer. Journal international du cancer 2005;117(2):221-9.
-
2005: Karenko Leena; Hahtola Sonja; Päivinen Suvi; Karhu Ritva; Syrjä Sanna; Kähkönen Marketta; Nedoszytko Boguslaw; Kytölä Soili; Zhou Ying; Blazevic Vesna; Pesonen Maria; Nevala Hanna; Nupponen Nina; Sihto Harri; Krebs Inge; Poustka Annemarie; Roszkiewicz Jadwiga; Saksela Kalle; Peterson Pärt; Visakorpi Tapio; Ranki Annamari
Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Cancer research 2005;65(18):8101-10.
-
2005: Bernard David; Martinez-Leal Juan F; Rizzo Sian; Martinez Dolores; Hudson David; Visakorpi Tapio; Peters Gordon; Carnero Amancio; Beach David; Gil Jesus
CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
Oncogene 2005;24(36):5543-51.
-
2005: Wallén Mika; Tomás Eija; Visakorpi Tapio; Holli Kaija; Mäenpää Johanna
Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.
Cancer chemotherapy and pharmacology 2005;55(4):343-6.
-
2004: Linja Marika J; Visakorpi Tapio
Alterations of androgen receptor in prostate cancer.
The Journal of steroid biochemistry and molecular biology 2004;92(4):255-64.
-
2004: Porkka Kati P; Visakorpi Tapio
Molecular mechanisms of prostate cancer.
European urology 2004;45(6):683-91.
-
2004: Savinainen K J; Linja M J; Saramäki O R; Tammela T L J; Chang G T G; Brinkmann A O; Visakorpi T
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
British journal of cancer 2004;90(5):1041-6.
-
2004: Wang Ruoxiang; Xu Jianchun; Saramäki Outi; Visakorpi Tapio; Sutherland William M; Zhou Jianguang; Sen Buer; Lim So Dug; Mabjeesh Nicola; Amin Mahul; Dong Jin-Tang; Petros John A; Nelson Peter S; Marshall Fray F; Zhau Haiyen E; Chung Leland W K
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
Cancer research 2004;64(5):1589-94.
-
2004: Linja Marika J; Porkka Kati P; Kang Zhikang; Savinainen Kimmo J; Jänne Olli A; Tammela Teuvo L J; Vessella Robert L; Palvimo Jorma J; Visakorpi Tapio
Expression of androgen receptor coregulators in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1032-40.
-
2004: Nupponen Nina N; Wallén Mika J; Ponciano Damaris; Robbins Christiane M; Tammela Teuvo L J; Vessella Robert L; Carpten John D; Visakorpi Tapio
Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Genes, chromosomes & cancer 2004;39(2):119-25.
-
2004: Porkka Kati P; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Genes, chromosomes & cancer 2004;39(1):1-10.
-
2004: Vleugel Marije M; Bos Reinhard; Buerger Horst; van der Groep Petra; Saramäki Outi R; Visakorpi Tapio; van der Wall Elsken; van Diest Paul J
No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2004;26(5-6):347-51.
-
2003: Junttila Teemu T; Laato Matti; Vahlberg Tero; Söderström Karl-Ove; Visakorpi Tapio; Isola Jorma; Elenius Klaus
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5346-57.
-
2003: Visakorpi Tapio
The molecular genetics of prostate cancer.
Urology 2003;62(5 Suppl 1):3-10.
-
2003: Porkka Kati P; Nupponen Nina N; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
Human pHyde is not a classical tumor suppressor gene in prostate cancer.
International journal of cancer. Journal international du cancer 2003;106(5):729-35.
-
2003: Linja Marika J; Savinainen Kimmo J; Tammela Teuvo L J; Isola Jorma J; Visakorpi Tapio
Expression of ERalpha and ERbeta in prostate cancer.
The Prostate 2003;55(3):180-6.
-
2002: Porkka Kati P; Helenius Merja A; Visakorpi Tapio
Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.
Laboratory investigation; a journal of technical methods and pathology 2002;82(11):1573-82.
-
2002: Laitinen Sari; Karhu Ritva; Sawyers Charles L; Vessella Robert L; Visakorpi Tapio
Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
Genes, chromosomes & cancer 2002;35(1):66-73.
-
2002: Schulz Wolfgang A; Elo Jussi P; Florl Andrea R; Pennanen Sari; Santourlidis Simon; Engers Rainer; Buchardt Martin; Seifert Hans-Helge; Visakorpi Tapio
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
Genes, chromosomes & cancer 2002;35(1):58-65.
-
2002: Kiuru Maija; Lehtonen Rainer; Arola Johanna; Salovaara Reijo; Järvinen Heikki; Aittomäki Kristiina; Sjöberg Jari; Visakorpi Tapio; Knuutila Sakari; Isola Jorma; Delahunt Brett; Herva Riitta; Launonen Virpi; Karhu Auli; Aaltonen Lauri A
Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
Cancer research 2002;62(16):4554-7.
-
2002: Joki-Erkkilä Minna M; Karikoski Riitta; Rantala Immo; Lenko Hanna-Liisa; Visakorpi Tapio; Heinonen Pentti K
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Journal of pediatric and adolescent gynecology 2002;15(3):145-9.
-
2002: Porkka Kati; Saramäki Outi; Tanner Minna; Visakorpi Tapio
Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.
Laboratory investigation; a journal of technical methods and pathology 2002;82(5):629-37.
-
2002: Leube Barbara; Drechsler Matthias; Mühlmann Kristina; Schäfer Reinhold; Schulz Wolfgang A; Santourlidis Simon; Anastasiadis Aristoteles; Ackermann Rolf; Visakorpi Tapio; Müller Wolfram; Royer-Pokora Brigitte
Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer.
The Prostate 2002;50(3):135-44.
-
2002: Savinainen Kimmo J; Saramäki Outi R; Linja Marika J; Bratt Ola; Tammela Teuvo L J; Isola Jorma J; Visakorpi Tapio
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
The American journal of pathology 2002;160(1):339-45.
-
2001: Saramäki O; Willi N; Bratt O; Gasser T C; Koivisto P; Nupponen N N; Bubendorf L; Visakorpi T
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
The American journal of pathology 2001;159(6):2089-94.
-
2001: Helenius M A; Saramäki O R; Linja M J; Tammela T L; Visakorpi T
Amplification of urokinase gene in prostate cancer.
Cancer research 2001;61(14):5340-4.
-
2001: Saramäki O R; Savinainen K J; Nupponen N N; Bratt O; Visakorpi T
Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer.
Cancer genetics and cytogenetics 2001;128(1):31-4.
-
2001: Isola J; Auvinen A; Poutiainen M; Kakkola L; Järvinen T A; Määttänen L; Stenman U H; Tammela T; Hakama M; Visakorpi T
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.
The Journal of urology 2001;165(5):1569-74.
-
2001: Linja M J; Savinainen K J; Saramäki O R; Tammela T L; Vessella R L; Visakorpi T
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Cancer research 2001;61(9):3550-5.
-
2001: Elo J P; Visakorpi T
Molecular genetics of prostate cancer.
Annals of medicine 2001;33(2):130-41.
-
2001: Pan Y; Lui W O; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim U S; Kytölä S
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Genes, chromosomes & cancer 2001;30(2):187-95.
-
2001: Porkka K P; Visakorpi T
Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array.
The Journal of pathology 2001;193(1):73-9.
-
2000: Palmberg C; Koivisto P; Kakkola L; Tammela T L; Kallioniemi O P; Visakorpi T
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
The Journal of urology 2000;164(6):1992-5.
-
2000: Hernes E H; Linja M; Fosså S D; Visakorpi T; Berner A; Winderen M; Koivisto P A
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.
BJU international 2000;86(3):240-7.
-
2000: Nupponen N N; Isola J; Visakorpi T
Mapping the amplification of EIF3S3 in breast and prostate cancer.
Genes, chromosomes & cancer 2000;28(2):203-10.
-
1999: Wallén M J; Linja M; Kaartinen K; Schleutker J; Visakorpi T
Androgen receptor gene mutations in hormone-refractory prostate cancer.
The Journal of pathology 1999;189(4):559-63.
-
1999: Palmberg C; Koivisto P; Visakorpi T; Tammela T L
PSA decline is an independent prognostic marker in hormonally treated prostate cancer.
European urology 1999;36(3):191-6.
-
1999: Nupponen N N; Porkka K; Kakkola L; Tanner M; Persson K; Borg A; Isola J; Visakorpi T
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
The American journal of pathology 1999;154(6):1777-83.
-
1999: Pan Y; Kytölä S; Farnebo F; Wang N; Lui W O; Nupponen N; Isola J; Visakorpi T; Bergerheim U S; Larsson C
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Cytogenetics and cell genetics 1999;87(3-4):225-32.
-
1999: Nupponen N N; Visakorpi T
Assignment of the protein kinase homolog of YAK1 (HIPK3) to human chromosome band 11p13 by in situ hybridization.
Cytogenetics and cell genetics 1999;87(1-2):102-3.
-
1999: Nupponen N; Visakorpi T
Molecular biology of progression of prostate cancer.
European urology 1999;35(5-6):351-4.
-
1999: Visakorpi T
Molecular genetics of prostate cancer.
Annales chirurgiae et gynaecologiae 1999;88(1):11-6.
-
1998: Nupponen N N; Kakkola L; Koivisto P; Visakorpi T
Genetic alterations in hormone-refractory recurrent prostate carcinomas.
The American journal of pathology 1998;153(1):141-8.
-
1998: Nupponen N N; Hyytinen E R; Kallioniemi A H; Visakorpi T
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization.
Cancer genetics and cytogenetics 1998;101(1):53-7.
-
1998: Koivisto P; Kolmer M; Visakorpi T; Kallioniemi O P
Androgen receptor gene and hormonal therapy failure of prostate cancer.
The American journal of pathology 1998;152(1):1-9.
-
1997: Koivisto P; Visakorpi T; Rantala I; Isola J
Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer.
The Journal of pathology 1997;183(1):51-6.
-
1997: Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Visakorpi T; Isola J
Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.
Genes, chromosomes & cancer 1997;18(2):94-101.
-
1997: Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Cancer research 1997;57(2):314-9.
-
1997: Palmberg C; Koivisto P; Hyytinen E; Isola J; Visakorpi T; Kallioniemi O P; Tammela T
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
European urology 1997;31(2):216-9.
-
1997: Hyytinen E R; Thalmann G N; Zhau H E; Karhu R; Kallioniemi O P; Chung L W; Visakorpi T
Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
British journal of cancer 1997;75(2):190-5.
-
1996: Hakama M; Holli K; Visakorpi T; Pekola M; Kallioniemi O P
Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis.
International journal of cancer. Journal international du cancer 1996;66(1):6-10.
-
1996: Vuorinen V; Sallinen P; Haapasalo H; Visakorpi T; Kallio M; Jääskeläinen J
Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices.
Acta neurochirurgica 1996;138(12):1399-408.
-
1996: Koivisto P; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1996;226():57-63.
-
1995: Koivisto P; Hyytinen E; Palmberg C; Tammela T; Visakorpi T; Isola J; Kallioniemi O P
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.
The American journal of pathology 1995;147(6):1608-14.
-
1995: Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi O P
In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Nature genetics 1995;9(4):401-6.
-
1995: Hakama M; Holli K; Isola J; Kallioniemi O P; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J
Aggressiveness of screen-detected breast cancers.
Lancet 1995;345(8944):221-4.
-
1995: Visakorpi T; Kallioniemi A H; Syvänen A C; Hyytinen E R; Karhu R; Tammela T; Isola J J; Kallioniemi O P
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Cancer research 1995;55(2):342-7.
-
1995: Visakorpi T; Holli K; Hakama M
High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(5):605-9.
-
1994: Sallinen P K; Haapasalo H K; Visakorpi T; Helén P T; Rantala I S; Isola J J; Helin H J
Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
The Journal of pathology 1994;174(4):275-82.
-
1994: Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi O P
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
The American journal of pathology 1994;145(3):624-30.
-
1994: Kallioniemi O P; Visakorpi T; Holli K; Isola J J; Rabinovitch P S
Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
Cytometry 1994;16(3):250-5.
-
1994: Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi O P; Isola J J
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry 1994;16(2):93-9.
-
1994: Visakorpi T; Kylmälä T; Tainio H; Koivula T; Tammela T; Isola J
High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):129-30.
-
1993: Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi O P
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):36-43.
-
1993: Visakorpi T; Kallioniemi O P; Koivula T; Isola J
New prognostic factors in prostatic carcinoma.
European urology 1993;24(4):438-49.
-
1992: Visakorpi T; Kallioniemi O P; Koivula T; Harvey J; Isola J
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(6):643-8.
-
1992: Visakorpi T
Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
The Journal of pathology 1992;168(1):7-13.
-
1992: Isola J; Visakorpi T; Holli K; Kallioniemi O P
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Journal of the National Cancer Institute 1992;84(14):1109-14.
-
1992: Visakorpi T; Kallioniemi O P; Heikkinen A; Koivula T; Isola J
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
Journal of the National Cancer Institute 1992;84(11):883-7.
-
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H H; Isola J J
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.
International journal of cancer. Journal international du cancer 1991;49(5):650-5.
-
1991: Hyöty M; Visakorpi T; Kallioniemi O P; Mattila J; Laippala P; Nordback I
Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
The European journal of surgery = Acta chirurgica 1991;157(10):595-600.
-
1991: Visakorpi T; Kallioniemi O P; Paronen I Y; Isola J J; Heikkinen A I; Koivula T A
Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
British journal of cancer 1991;64(3):578-82.
-
1991: Kallioniemi O P; Visakorpi T; Holli K; Heikkinen A; Isola J; Koivula T
Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.
Cytometry 1991;12(5):413-21.
-
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H; Isola J
[New studies on breast cancer to predict disease outcome and clinical use of these new tests]
Duodecim; lääketieteellinen aikakauskirja 1991;107(11):907-16.
-
1987: Visakorpi T; Vilja P; Kulomaa M; Tuohimaa P; Klockars M
Cerebrospinal fluid lactoferrin in bacterial and viral meningitis.
Acta paediatrica Scandinavica 1987;76(6):987-8.
Sign-in to see more